Target detail
ADA
adenosine deaminase
Data: Live structured evidence (Supabase)
Foundation row from public.targets — full Open Targets / ChEMBL preload remains a future operator job (Phase 8H+).
Display name: adenosine deaminase
Aliases: ADA, adenosine deaminase
Type / organism: protein_coding · Homo sapiens
Source: opentargets · ENSG00000196839
Index freshness: last_synced_at 2026-05-15T19:48:06.844+00:00 · updated 2026-05-15T19:48:07.306442+00:00
Limitations & build flags
- Read-only structured navigator
- No clinical outcome benefit inferred
- Trial presence does not imply success
- Drug identity may require normalization
- Terminated/withdrawn trials must remain visible
This symbol is listed in public.targets (operator seed or future preload). Connector-backed sections below may still show empty states until ChEMBL / Open Targets / ClinicalTrials.gov mirror rows exist for this marker.
Connectors represented in loaded rows for ADA. Empty groups mean no matching rows — not a claim about biology or clinical use.
- ClinicalTrials.govLive when indexed
Registry mirror rows in clinical_trials when operators run the CT.gov enrichment CLI — browser never calls the registry directly.
- Open TargetsLive when indexed
Disease–target evidence rows when operators run enrich:opentargets (GraphQL from trusted scripts only).
- ChEMBLLive when indexed
Drug–target and related enrichment rows when operators run enrich:chembl (server/CLI only).
Rows from disease_target_evidence for this symbol.
glioblastoma
literature · opentargets
Drug records tied via drug_targets — mechanistic linkage only.
CHEMBL5998816
chembl5998816
CHEMBL1766274
chembl1766274
CHEMBL6029062
chembl6029062
CHEMBL1651379
chembl1651379
CHEMBL334197
chembl334197
CHEMBL6063238
chembl6063238
CHEMBL5785869
chembl5785869
CHEMBL5917368
chembl5917368
CHEMBL340297
chembl340297
CHEMBL5834802
chembl5834802
CHEMBL17822
chembl17822
CHEMBL6051235
chembl6051235
CHEMBL6057817
chembl6057817
CHEMBL5895135
chembl5895135
CHEMBL5795227
chembl5795227
CHEMBL6029118
chembl6029118
CHEMBL6064811
chembl6064811
CHEMBL6061002
chembl6061002
CHEMBL6021518
chembl6021518
CHEMBL6004227
chembl6004227
CHEMBL5846009
chembl5846009
CHEMBL5793140
chembl5793140
CHEMBL5996832
chembl5996832
CHEMBL5913503
chembl5913503
CHEMBL5967448
chembl5967448
CHEMBL14106
chembl14106
CHEMBL118106
chembl118106
CHEMBL5942245
chembl5942245
CHEMBL122016
chembl122016
CHEMBL5787488
chembl5787488
CHEMBL6059148
chembl6059148
CHEMBL5787523
chembl5787523
CHEMBL5925464
chembl5925464
CHEMBL1766276
chembl1766276
CHEMBL1766280
chembl1766280
CHEMBL13697
chembl13697
CHEMBL1766200
chembl1766200
CHEMBL6038528
chembl6038528
CHEMBL5928708
chembl5928708
CHEMBL5934409
chembl5934409
CHEMBL5907120
chembl5907120
CHEMBL5764560
chembl5764560
CHEMBL5888872
chembl5888872
CHEMBL5908174
chembl5908174
CHEMBL5764390
chembl5764390
CHEMBL5842576
chembl5842576
CHEMBL5878780
chembl5878780
CHEMBL435971
chembl435971
CHEMBL5796203
chembl5796203
CHEMBL5981055
chembl5981055
CHEMBL6020558
chembl6020558
CHEMBL5971003
chembl5971003
CHEMBL6005013
chembl6005013
CHEMBL5861409
chembl5861409
CHEMBL6050525
chembl6050525
CHEMBL5910313
chembl5910313
CHEMBL5780320
chembl5780320
CHEMBL1766195
chembl1766195
CHEMBL6037722
chembl6037722
CHEMBL121714
chembl121714
CHEMBL115824
chembl115824
CHEMBL5878173
chembl5878173
CHEMBL18659
chembl18659
CHEMBL274888
chembl274888
CHEMBL5961666
chembl5961666
CHEMBL5824256
chembl5824256
CHEMBL5759530
chembl5759530
CHEMBL5828556
chembl5828556
CHEMBL5653589
chembl5653589
CHEMBL274814
chembl274814
CHEMBL1651378
chembl1651378
CHEMBL6005219
chembl6005219
CHEMBL338076
chembl338076
CHEMBL610668
chembl610668
CHEMBL1651377
chembl1651377
CHEMBL341867
chembl341867
CHEMBL5781383
chembl5781383
CHEMBL340086
chembl340086
CHEMBL5937343
chembl5937343
CHEMBL329433
chembl329433
CHEMBL6000417
chembl6000417
CHEMBL359803
chembl359803
CHEMBL5955399
chembl5955399
CHEMBL6054132
chembl6054132
CORDYCEPIN
chembl305686
CHEMBL125386
chembl125386
CHEMBL5894696
chembl5894696
CHEMBL18838
chembl18838
CHEMBL5830230
chembl5830230
CHEMBL6000857
chembl6000857
CHEMBL5973239
chembl5973239
CHEMBL6036466
chembl6036466
CHEMBL5863520
chembl5863520
CHEMBL5889072
chembl5889072
CHEMBL5757568
chembl5757568
NEBULARINE
chembl1399702
CHEMBL5952880
chembl5952880
CHEMBL327830
chembl327830
CHEMBL5958825
chembl5958825
CHEMBL1766197
chembl1766197
CHEMBL6013235
chembl6013235
CHEMBL123620
chembl123620
CONFORMYCIN
chembl604966
CHEMBL5759921
chembl5759921
CHEMBL132108
chembl132108
CHEMBL1766278
chembl1766278
CHEMBL124728
chembl124728
CHEMBL93647
chembl93647
CHEMBL5851174
chembl5851174
CHEMBL5776283
chembl5776283
CHEMBL5900204
chembl5900204
CHEMBL5884252
chembl5884252
GS-441524
chembl2016757
CHEMBL5813207
chembl5813207
CHEMBL5816606
chembl5816606
CHEMBL6001262
chembl6001262
CHEMBL93560
chembl93560
CHEMBL6043910
chembl6043910
CHEMBL5961183
chembl5961183
CHEMBL5755688
chembl5755688
CHEMBL1766194
chembl1766194
CHEMBL5830787
chembl5830787
CHEMBL1766277
chembl1766277
CHEMBL6005207
chembl6005207
CHEMBL5974781
chembl5974781
OBELDESIVIR
chembl4863829
CHEMBL5932870
chembl5932870
CHEMBL1766201
chembl1766201
CHEMBL5998906
chembl5998906
CHEMBL5874227
chembl5874227
CHEMBL5968574
chembl5968574
CHEMBL5751810
chembl5751810
CHEMBL5972430
chembl5972430
CHEMBL5788860
chembl5788860
CHEMBL5947416
chembl5947416
CHEMBL5823568
chembl5823568
CHEMBL5815466
chembl5815466
CHEMBL5783482
chembl5783482
CHEMBL5809185
chembl5809185
CHEMBL5953271
chembl5953271
CHEMBL5946090
chembl5946090
CHEMBL5894277
chembl5894277
CHEMBL3110070
chembl3110070
CHEMBL93280
chembl93280
CHEMBL5884259
chembl5884259
CHEMBL1911735
chembl1911735
CHEMBL1766199
chembl1766199
CHEMBL5763819
chembl5763819
CHEMBL5940159
chembl5940159
CHEMBL6005828
chembl6005828
CHEMBL5864735
chembl5864735
CHEMBL92404
chembl92404
CHEMBL6051107
chembl6051107
COFORMYCIN
chembl284483
CHEMBL5809488
chembl5809488
FR-221647
chembl13696
CHEMBL5767359
chembl5767359
CHEMBL6010741
chembl6010741
CHEMBL5971518
chembl5971518
CHEMBL6049436
chembl6049436
CHEMBL5953112
chembl5953112
CHEMBL328139
chembl328139
CHEMBL5760811
chembl5760811
CHEMBL6021278
chembl6021278
CHEMBL332440
chembl332440
CHEMBL5861367
chembl5861367
CHEMBL5933763
chembl5933763
CHEMBL6040259
chembl6040259
CHEMBL5818178
chembl5818178
CHEMBL2112110
chembl2112110
CHEMBL3290657
chembl3290657
(+)-EHNA
chembl296435
CHEMBL5814163
chembl5814163
CHEMBL5956235
chembl5956235
CHEMBL5892750
chembl5892750
8-AZA-NEBULARINE
chembl1651380
CHEMBL5955660
chembl5955660
CHEMBL5851835
chembl5851835
CHEMBL5781346
chembl5781346
CHEMBL6044636
chembl6044636
CHEMBL436332
chembl436332
CHEMBL5780104
chembl5780104
CHEMBL6049476
chembl6049476
CHEMBL6032424
chembl6032424
CHEMBL5802417
chembl5802417
CHEMBL5937505
chembl5937505
CHEMBL6013260
chembl6013260
CHEMBL5897248
chembl5897248
CHEMBL5925149
chembl5925149
CHEMBL5864158
chembl5864158
CHEMBL5818798
chembl5818798
CHEMBL5904307
chembl5904307
CHEMBL5928603
chembl5928603
CHEMBL96772
chembl96772
CHEMBL1766196
chembl1766196
AFAMELANOTIDE
chembl441738
CHEMBL1911841
chembl1911841
CHEMBL6039461
chembl6039461
CHEMBL125275
chembl125275
CHEMBL5822556
chembl5822556
disease_drug_evidence rows on linked drugs whose evidence_type suggests approved-elsewhere discussion context.
No matching rows
Import repoDB-compatible disease–drug evidence or add structured rows to surface discussion candidates here.
Mirror rows whose text fields mention this symbol — registry context only.
NCT05909618 — Crizanlizumab Alone or in Combination With Nivolumab for Glioblastoma and Melanoma With Brain Metastases
Status: RECRUITING · clinicaltrials.gov
Open trials hubNCT03477513 — Personalized Radiation Therapy for GBM
Status: ACTIVE_NOT_RECRUITING · clinicaltrials.gov
Open trials hubNCT01849146 — Adavosertib, Radiation Therapy, and Temozolomide in Treating Patients With Newly Diagnosed or Recurrent Glioblastoma
Status: COMPLETED · clinicaltrials.gov
Open trials hubNCT06492486 — Glioma Adaptive Radiotherapy With Development of an Artificial Intelligence Workflow
Status: NOT_YET_RECRUITING · clinicaltrials.gov
Open trials hubNCT06264388 — DB107-Retroviral Replicating Vector (RRV) Combined With DB107-Flucytosine (FC) in Patients With Recurrent Glioblastoma or Anaplastic Astrocytoma
Status: RECRUITING · clinicaltrials.gov
Open trials hubRepurposing signal rows for drugs linked to this target via drug_targets.
No research signals for linked drugs
Run the deterministic signal builder after drug_targets and source rows are present.
Structured rows with negative evidence_direction on disease–drug or signal tables.
No negative-direction rows
When structured evidence includes explicit negative direction fields, they surface here for oncology review.
- chembl: 274
- clinicaltrials.gov: 6
- opentargets: 1
Structured evidence rows link this marker to cohort contexts when ingested — interpret as research context only.
Disease contexts
0
Linked drugs
0
Linked in dataset
0
Research signals
0
Doctor-discussion candidate and related tags are descriptive only.
Signals list: Live structured evidence (Supabase)
No matching live evidence found
When repurposing_signal rows reference this marker via linked drugs, summaries appear here.